Hyperuricemia is a Adverse Prognostic Factor for Colon Cancer Patients

References

• Sideris M, Papagrigoriadis S. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. Anticancer Res. 2014;34(5):2061–2068. PMID: 24778007.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375(9719):1030–1047. doi:10.1016/S0140-6736(10)60353-4
   PubMed Web of Science ®Google Scholar
• Audisio RA, Papamichael D. Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol. 2012;9:716–725. doi:10.1038/nrgastro.2012.196
   PubMed Web of Science ®Google Scholar
• Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013;56(11):1304–1319. doi:10.1097/DCR.0b013e3182a479f9
   PubMed Web of Science ®Google Scholar
• Xiao L, Zheng K, Lv X, et al. Exo70 is an independent prognostic factor in colon cancer. Sci Rep. 2017;7(1):5039. doi:10.1038/s41598-017-05308-x.
   PubMed Web of Science ®Google Scholar
• Ren Y, Lv Y, Li T, Jiang Q. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: a study based on TCGA data. Gene. 2020;763:145072. doi:10.1016/j.gene.2020.145072.
   PubMed Web of Science ®Google Scholar
• Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145–4151. doi:10.2174/138161205774913255
   PubMed Web of Science ®Google Scholar
• Kang DH, Ha SK. Uric acid puzzle: dual role as anti-oxidantand pro-oxidant. Electrolyte Blood Press. 2014;12(1):1–6. doi:10.5049/EBP.2014.12.1.1
   PubMedGoogle Scholar
• Fang P, Li X, Luo JJ, Wang H, Yang XF. A double-edged sword: uric acid and neurological disorders. Brain Disord Ther. 2013;2(2):109. doi:10.4172/2168-975X.1000109
   PubMedGoogle Scholar
• Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11(4):385–391. PMID:11927499.
   PubMed Web of Science ®Google Scholar
• Horsfall LJ, Nazareth I, Petersen I. Serum uric acid and the risk of respiratory disease: a population-based cohort study. Thorax. 2014;69(11):1021–1026. doi:10.1136/thoraxjnl-2014-205271
   PubMed Web of Science ®Google Scholar
• Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858–6862. doi:10.1073/pnas.78.11.6858
   PubMed Web of Science ®Google Scholar
• Strasak AM, Rapp K, Hilbe W, et al. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control. 2007;18(9):1021–1029. doi:10.1007/s10552-007-9043-3
   PubMed Web of Science ®Google Scholar
• Amri R, Bordeianou LG, Berger DL. Effect of high-grade disease on outcomes of surgically treated colon cancer. Ann Surg Oncol. 2016;23(4):1157–1163. doi:10.1245/s10434-015-4983-4
   PubMed Web of Science ®Google Scholar
• Minsky B, Mies C. The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum. 1989;32(9):794–803. doi:10.1007/BF02562132
   PubMed Web of Science ®Google Scholar
• Chen J, Ye Y, Sun H, Shi G. Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis. Cancer Chemother Pharmacol. 2013;71(1):265–272. doi:10.1007/s00280-012-2005-9
   PubMed Web of Science ®Google Scholar
• Ye F, Liu Z, Tan A, Liao M, Mo Z, Yang X. XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis. Cancer Chemother Pharmacol. 2013;71(3):733–740. doi:10.1007/s00280-012-2067-8
   PubMed Web of Science ®Google Scholar
• Yan S, Zhang P, Xu W, et al. Serum uric acid increases risk of cancer incidence and mortality: a systematic review and meta-analysis. Mediators Inflamm. 2015;2015:764250. doi:10.1155/2015/764250
   PubMed Web of Science ®Google Scholar
• Wang W, Xu D, Wang B, et al. Increased risk of cancer in relation to Gout: a review of three prospective Cohort Studies with 50,358 subjects. Mediators Inflamm. 2015;2015:680853. doi:10.1155/2015/680853
   PubMed Web of Science ®Google Scholar
• Okazaki H, Shirakabe A, Kobayashi N, et al. The prognostic impact of uric acid in patients with severely decompensated acute heart failure. J Cardiol. 2016;68(5):384–391. doi:10.1016/j.jjcc.2016.04.013
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang Y, Ding D, et al. Association between serum uric acid and mortality among Chinese patients with coronary artery disease. Cardiology. 2016;134(3):347–356. doi:10.1159/000443518
   PubMed Web of Science ®Google Scholar
• Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis. 2013;231(1):61–68. doi:10.1016/j.atherosclerosis.2013.08.023
   PubMed Web of Science ®Google Scholar
• Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH. Increased risk of cancer among gout patients: a nationwide population study. Joint Bone Spine. 2012;79(4):375–378. doi:10.1016/j.jbspin.2011.09.011
   PubMed Web of Science ®Google Scholar
• Strasak AM, Rapp K, Hilbe W, et al. The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol. 2007;18(11):1893–1897. doi:10.1093/annonc/mdm338
   PubMed Web of Science ®Google Scholar
• Fini MA, Elias A, Johnson RJ, Wright RM. Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Transl Med. 2012;1(1):16. doi:10.1186/2001-1326-1-16
   PubMedGoogle Scholar
• Baeksgaard L, Sørensen JB. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Cancer Chemother Pharmacol. 2003;51(3):187–192. doi:10.1007/s00280-002-0556-x
   PubMed Web of Science ®Google Scholar
• Wannamethee SG. Serum uric acid and risk of coronary heart disease. Curr Pharm Des. 2005;11(32):4125–4132. doi:10.2174/138161205774913200
   PubMed Web of Science ®Google Scholar
• Kalemkerian GP, Darwish B, Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med. 1997;103(5):363–367. doi:10.1016/s0002-9343(97)00153-8
   PubMed Web of Science ®Google Scholar
• Tanriverdi O, Cokmert S, Oktay E, et al. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group. Med Oncol. 2014;31(10):217. doi:10.1007/s12032-014-0217-z
   PubMed Web of Science ®Google Scholar
• Wang S, Liu X, He Z, Chen X, Li W. Hyperuricemia has an adverse impact on the prognosis of patients with osteosarcoma. Tumour Biol. 2016;37(1):1205–1210. doi:10.1007/s13277-015-3830-3
   PubMedGoogle Scholar
• Szkandera J, Gerger A, Liegl-Atzwanger B, et al. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients. Clin Chem Lab Med. 2015;53(3):493–497. doi:10.1515/cclm-2014-0486
   PubMed Web of Science ®Google Scholar